Early Adenoviral Gene Expression Mediates Immunosuppression by Transduced Dendritic Cell (DC): Implications for Immunotherapy Using Genetically Modified DC1
暂无分享,去创建一个
A. Enk | S. Kochanek | T. Tüting | H. Jonuleit | A. Tuettenberg | J. Knop | J. Brück | V. Biermann
[1] H. Nisenbaum,et al. Intranodal administration of peptide-pulsed mature dendritic cell vaccines results in superior CD8+ T-cell function in melanoma patients. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] M. Roth,et al. Helper-Dependent Adenoviral Vectors Efficiently Express Transgenes in Human Dendritic Cells but Still Stimulate Antiviral Immune Responses1 , 2002, The Journal of Immunology.
[3] S. Kochanek,et al. A DNA-based method to assay total and infectious particle contents and helper virus contamination in high-capacity adenoviral vector preparations. , 2002, Human gene therapy.
[4] A. Enk,et al. A comparison of two types of dendritic cell as adjuvants for the induction of melanoma‐specific T‐cell responses in humans following intranodal injection , 2001, International journal of cancer.
[5] S. Kochanek,et al. Comparison of long-term transgene expression after non-viral and adenoviral gene transfer into primary articular chondrocytes , 2001, Histochemistry and Cell Biology.
[6] J. Hauber,et al. Mature Dendritic Cells Infected with Herpes Simplex Virus Type 1 Exhibit Inhibited T-Cell Stimulatory Capacity , 2000, Journal of Virology.
[7] M. Eichelberger,et al. Dose-Dependent Changes in Influenza Virus-Infected Dendritic Cells Result in Increased Allogeneic T-Cell Proliferation at Low, but Not High, Doses of Virus , 2000, Journal of Virology.
[8] G. Linette,et al. In Vitro Priming with Adenovirus/gp100 Antigen-Transduced Dendritic Cells Reveals the Epitope Specificity of HLA-A*0201-Restricted CD8+ T Cells in Patients with Melanoma1 , 2000, Journal of Immunology.
[9] P. Vidalain,et al. Measles Virus Induces Abnormal Differentiation of CD40 Ligand-Activated Human Dendritic Cells1 , 2000, The Journal of Immunology.
[10] A. Enk,et al. Efficient transduction of mature CD83+ dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacity , 2000, Gene Therapy.
[11] R. Steinman,et al. Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. , 1999, Journal of immunology.
[12] A. Enk,et al. Dendritic cell‐based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti‐melanoma immunity , 1999, The journal of gene medicine.
[13] O. Majdic,et al. Human major group rhinoviruses downmodulate the accessory function of monocytes by inducing IL-10. , 1999, The Journal of clinical investigation.
[14] R. Steinman,et al. Recombinant adenovirus is an efficient and non‐perturbing genetic vector for human dendritic cells , 1999, European journal of immunology.
[15] P. Seth,et al. Recombinant, Replication-Defective Adenovirus Gene Transfer Vectors Induce Cell Cycle Dysregulation and Inappropriate Expression of Cyclin Proteins , 1998, Journal of Virology.
[16] L. Butterfield,et al. Generation of CD8+ and CD4+ T-cell response to dendritic cells genetically engineered to express the MART-1/Melan-A gene. , 1998, Cancer research.
[17] A. Ribas,et al. Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovirus. , 1998, Journal of immunology.
[18] R. Steinman,et al. Dendritic cells and the control of immunity , 1998, Nature.
[19] Dirk Schadendorf,et al. Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells , 1998, Nature Medicine.
[20] A. Enk,et al. Pro‐inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum‐free conditions , 1997, European journal of immunology.
[21] V. ter meulen,et al. Cell cycle arrest rather than apoptosis is associated with measles virus contact-mediated immunosuppression in vitro. , 1997, The Journal of general virology.
[22] S. Rafii,et al. Dendritic Cells Genetically Modified with an Adenovirus Vector Encoding the cDNA for a Model Antigen Induce Protective and Therapeutic Antitumor Immunity , 1997, The Journal of experimental medicine.
[23] S. Rosenberg,et al. Dendritic Cells Retrovirally Transduced with a Model Antigen Gene Are Therapeutically Effective against Established Pulmonary Metastases , 1997, The Journal of experimental medicine.
[24] R. Steinman,et al. Dendritic Cells as Adjuvants for Immune-mediated Resistance to Tumors , 1997, The Journal of experimental medicine.
[25] D. Kufe,et al. Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells , 1997, Gene Therapy.
[26] M. Lotze,et al. Genetically modified bone marrow‐derived dendritic cells expressing tumor‐associated viral or “self” antigens induce antitumor immunity in vivo , 1997, European journal of immunology.
[27] J. Banchereau,et al. Measles Virus Infects Human Dendritic Cells and Blocks Their Allostimulatory Properties for CD4+ T Cells , 1997, The Journal of experimental medicine.
[28] C. Rabourdin-Combe,et al. Measles Virus Suppresses Cell-mediated Immunity by Interfering with the Survival and Functions of Dendritic and T Cells , 1997, The Journal of experimental medicine.
[29] F. Graham,et al. Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination. , 1997, Human gene therapy.
[30] M. Kitamura,et al. Construction of adenovirus vectors through Cre-lox recombination , 1997, Journal of virology.
[31] M. Billeter,et al. Interaction of measles virus glycoproteins with the surface of uninfected peripheral blood lymphocytes induces immunosuppression in vitro. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[32] S. H. van der Burg,et al. Peptide‐pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA‐A*0201‐binding peptides from the Melan‐A/MART‐1 self antigen , 1996, European journal of immunology.
[33] M. Mohamadzadeh,et al. Increased level of intracellular MHC class II molecules in murine Langerhans cells following in vivo and in vitro administration of contact allergens. , 1992, The Journal of investigative dermatology.
[34] M. Oldstone,et al. Measles virus inhibits mitogen-induced T cell proliferation but does not directly perturb the T cell activation process inside the cell. , 1992, Virology.
[35] C. Nathan,et al. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. , 1988, Journal of immunology.
[36] A. Altman,et al. Suppression of T lymphocyte function by measles virus is due to cell cycle arrest in G1. , 1988, Journal of immunology.
[37] R. Steinman,et al. The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.